Director of Health Economics Outcomes Research
ArineFull Time
Expert & Leadership (9+ years)
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.
Abbott is a global healthcare leader, creating breakthrough science to improve people’s health. We’re always looking towards the future, anticipating changes in medical science and technology.
At Abbott, you can do work that matters, grow, and learn, care for yourself and your family, be your true self, and live a full life. You’ll also have access to:
This position is an office based or remote opportunity in the Abbott Diabetes Care Division. We are helping people with Diabetes lead healthier, happier lives.
As a global leader in diabetes care, Abbott is constantly working to deliver the highest quality products and unwavering support to our customers. Consistent and accurate glucose monitoring is the foundation of any diabetes management plan, so we’re committed to continuous improvement in the way patients and professionals measure, track and analyze glucose levels.
As a global Health Economics and Outcomes Research manager, your primary responsibility is to support market access activities for the ADC portfolio with the aim of ensuring strong brand uptake and growth worldwide, specifically by developing and delivering HEOR strategies and tactics that target the multiple stakeholders who make or influence decisions on the funding and use of ADC products. They will work in close collaboration with key cross functional partners primarily in EMEA region but also across the US, LATAM, and APAC regions to initiate and execute Health Economic analyses, Outcomes Research/RWE studies and Market Access initiatives to maximize and protect patient access globally across the product life cycle.
This team member will be highly experienced and knowledgeable in delivering departmental strategy through creation and maintenance of tools and resources, education and training on reimbursement principles, and building relationships both internally and externally with co-workers, physicians and health economic opinion leaders. They will serve as a “content expert” on issue related to HEOR and HTA; they will have responsibility for scientific soundness of activities, and ensure outcomes aligned with Global and regional payer needs. They will partner with a worldwide community of well recognized experts/KOLs to ensure the development of state-of-the-art Health Economic and Outcomes Research studies.
Key internal customers may include global affiliate MA leads, new product planning teams, clinical science and operations, medical affairs, marketing commercial teams and Government Affairs. Key external customers may include provider customers (physicians, registry or database director, hospital economic buyers…), private payers, HTA body, government agencies, physician societies, KOLs and industry trade associations.
Full time
Healthcare solutions in diagnostics and devices
Abbott Laboratories focuses on improving health through various medical technologies and health solutions. The company operates in areas such as cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's products include advanced medical devices and diagnostic tests that help healthcare professionals and patients manage health conditions effectively. For example, their cardiovascular technologies assist in heart health management, while diabetes care products enable accurate glucose monitoring without painful fingersticks. Unlike many competitors, Abbott emphasizes accessibility and affordability in its offerings, aiming to make life-changing technologies available to a broader audience. The company's goal is to positively impact global health and well-being, supported by a commitment to sustainability and a 2030 Sustainability Plan.